
Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices
Career Award (K) Policy Update: Concurrent Support from a Mentored K Award and a Research Grant
(NOT-OD-18-157) Office of the Director, NIH
(NOT-OD-18-157) Office of the Director, NIH
Change to Activity Codes for PA-18-713: Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional)
(NOT-OD-18-163) Office of the Director, NIH
(NOT-OD-18-163) Office of the Director, NIH
NCI Announcement of Interest in Supporting Immuno-Oncology Research and Career Development through NIH Parent PA-18-591, "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)"
(NOT-CA-18-056)
National Cancer Institute
(NOT-CA-18-056)
National Cancer Institute
Request for Information (RFI): NHLBI R35 Programs
(NOT-HL-18-614)
National Heart, Lung, and Blood Institute
(NOT-HL-18-614)
National Heart, Lung, and Blood Institute
Requests for Applications
Limited Competition: Building Infrastructure Leading to Diversity (BUILD) Initiative Phase II (U54 Clinical Trial Not Allowed)
(RFA-RM-18-006)
Office of Strategic Coordination (Common Fund)
(RFA-RM-18-006)
Office of Strategic Coordination (Common Fund)
Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed)
(RFA-RM-18-011)
Office of Strategic Coordination (Common Fund)
(RFA-RM-18-011)
Office of Strategic Coordination (Common Fund)
Program Announcements
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
(PAR-18-740)
National Heart, Lung, and Blood Institute
(PAR-18-740)
National Heart, Lung, and Blood Institute
No hay comentarios:
Publicar un comentario